ID   R4I4P2_9CALI            Unreviewed;       540 AA.
AC   R4I4P2;
DT   24-JUL-2013, integrated into UniProtKB/TrEMBL.
DT   24-JUL-2013, sequence version 1.
DT   03-AUG-2022, entry version 37.
DE   SubName: Full=Major capsid protein {ECO:0000313|EMBL:AFJ04708.1};
OS   Norovirus Hu/GII.4/Farmington Hills/2004/USA.
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Picornavirales; Caliciviridae; Norovirus.
OX   NCBI_TaxID=1182143 {ECO:0000313|EMBL:AFJ04708.1};
RN   [1] {ECO:0000313|EMBL:AFJ04708.1}
RP   NUCLEOTIDE SEQUENCE.
RC   STRAIN=GII.4/Farmington Hills/2004 {ECO:0000313|EMBL:AFJ04708.1};
RX   PubMed=22090098; DOI=10.1128/JVI.06200-11;
RA   Lindesmith L.C., Debbink K., Swanstrom J., Vinje J., Costantini V.,
RA   Baric R.S., Donaldson E.F.;
RT   "Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.";
RL   J. Virol. 86:873-883(2012).
RN   [2] {ECO:0007829|PDB:4OPV}
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 225-530.
RA   Singh B.K., Leuthold M.M., Hansman G.S.;
RT   "Unliganded crystal structure of P domain from norovirus strain Farmington
RT   Hills 2004 co-crystallized with HBGA type Lea.";
RL   Submitted (FEB-2014) to the PDB data bank.
RN   [3] {ECO:0007829|PDB:4OOV, ECO:0007829|PDB:4OPS}
RP   X-RAY CRYSTALLOGRAPHY (1.53 ANGSTROMS) OF 225-530 IN COMPLEX WITH FUCOSE
RP   AND GALACTOSE.
RX   PubMed=25428879; DOI=10.1128/JVI.02968-14;
RA   Singh B.K., Leuthold M.M., Hansman G.S.;
RT   "Human noroviruses' fondness for histo-blood group antigens.";
RL   J. Virol. 89:2024-2040(2015).
RN   [4] {ECO:0007829|PDB:6N81, ECO:0007829|PDB:6N8D}
RP   X-RAY CRYSTALLOGRAPHY (2.58 ANGSTROMS) OF 225-530.
RX   PubMed=31216462; DOI=10.1016/j.immuni.2019.05.007;
RA   Lindesmith L.C., McDaniel J.R., Changela A., Verardi R., Kerr S.A.,
RA   Costantini V., Brewer-Jensen P.D., Mallory M.L., Voss W.N., Boutz D.R.,
RA   Blazeck J.J., Ippolito G.C., Vinje J., Kwong P.D., Georgiou G., Baric R.S.;
RT   "Sera Antibody Repertoire Analyses Reveal Mechanisms of Broad and Pandemic
RT   Strain Neutralizing Responses after Human Norovirus Vaccination.";
RL   Immunity 50:1530-1541.e8(2019).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; JQ478408; AFJ04708.1; -; Genomic_RNA.
DR   PDB; 4OOV; X-ray; 1.53 A; A/B=225-530.
DR   PDB; 4OPS; X-ray; 1.76 A; A/B=225-530.
DR   PDB; 4OPV; X-ray; 1.85 A; A/B=225-530.
DR   PDB; 4X05; X-ray; 1.98 A; A/B/C/D=225-530.
DR   PDB; 6N81; X-ray; 2.58 A; A/B=225-530.
DR   PDB; 6N8D; X-ray; 3.10 A; A/C=225-530.
DR   PDBsum; 4OOV; -.
DR   PDBsum; 4OPS; -.
DR   PDBsum; 4OPV; -.
DR   PDBsum; 4X05; -.
DR   PDBsum; 6N81; -.
DR   PDBsum; 6N8D; -.
DR   SMR; R4I4P2; -.
DR   UniLectin; R4I4P2; -.
DR   ABCD; R4I4P2; 2 sequenced antibodies.
DR   CDD; cd00205; rhv_like; 1.
DR   Gene3D; 2.60.120.20; -; 1.
DR   InterPro; IPR004005; Calicivirus_coat.
DR   InterPro; IPR013643; Calicivirus_coat_C.
DR   InterPro; IPR033703; Rhv-like.
DR   InterPro; IPR029053; Viral_coat.
DR   Pfam; PF00915; Calici_coat; 1.
DR   Pfam; PF08435; Calici_coat_C; 1.
PE   1: Evidence at protein level;
KW   3D-structure {ECO:0007829|PDB:4OOV, ECO:0007829|PDB:4OPS}.
FT   DOMAIN          12..276
FT                   /note="Calici_coat"
FT                   /evidence="ECO:0000259|Pfam:PF00915"
FT   DOMAIN          305..538
FT                   /note="Calici_coat_C"
FT                   /evidence="ECO:0000259|Pfam:PF08435"
FT   BINDING         310
FT                   /ligand="Galactose"
FT                   /ligand_id="ChEBI:CHEBI:27667"
FT                   /evidence="ECO:0007829|PDB:4OPS"
FT   BINDING         344
FT                   /ligand="Fucose"
FT                   /ligand_id="ChEBI:CHEBI:42548"
FT                   /evidence="ECO:0007829|PDB:4OPS, ECO:0007829|PDB:4X05"
FT   BINDING         345
FT                   /ligand="Fucose"
FT                   /ligand_id="ChEBI:CHEBI:42548"
FT                   /evidence="ECO:0007829|PDB:4OPS, ECO:0007829|PDB:4X05"
FT   BINDING         374
FT                   /ligand="Fucose"
FT                   /ligand_id="ChEBI:CHEBI:42548"
FT                   /evidence="ECO:0007829|PDB:4OPS, ECO:0007829|PDB:4X05"
FT   BINDING         391
FT                   /ligand="Fucose"
FT                   /ligand_id="ChEBI:CHEBI:42548"
FT                   /evidence="ECO:0007829|PDB:4OPS"
FT   BINDING         392
FT                   /ligand="Fucose"
FT                   /ligand_id="ChEBI:CHEBI:42548"
FT                   /evidence="ECO:0007829|PDB:4OPS"
FT   BINDING         442
FT                   /ligand="Galactose"
FT                   /ligand_id="ChEBI:CHEBI:27667"
FT                   /evidence="ECO:0007829|PDB:4OPS"
FT   BINDING         443
FT                   /ligand="Fucose"
FT                   /ligand_id="ChEBI:CHEBI:42548"
FT                   /evidence="ECO:0007829|PDB:4X05"
SQ   SEQUENCE   540 AA;  58950 MW;  1246BCDE22823A21 CRC64;
     MKMASNDANP SDGSTANLVP EVNNEVMALE PVVGAAIAAP VAGQQNVIDP WIRNNFVQAP
     GGEFTVSPRN APGEILWSAP LGPDLNPYLS HLARMYNGYA GGFEVQVILA GNAFTAGKII
     FAAVPPNFPT EGLSPSQVTM FPHIIVDVRQ LEPVLIPLPD VRNNFYHYNQ SNDPTIKLIA
     MLYTPLRANN AGEDVFTVSC RVLTRPSPDF DFIFLVPPTV ESRTKPFTVP ILTVEEMTNS
     RFPIPLEKLF TGPSGAFVVQ PQNGRCTTDG VLLGTTQLSP VNICTFRGDV THIAGTHNYT
     MNLASQNWNN YDPTEEIPAP LGTPDFVGRI QGMLTQTTRG DGSTRGHKAT VSTGDVHFTP
     KLGSIQFNTD TNNDFETGQN TKFTPVGVVQ DGNGAHQNEP QQWVLPSYSG RTGHNVHLAP
     AVAPTFPGEQ LLFFRSTMPG CSGYPNMNLD CLLPQEWVQH FYQEAAPAQS DVALLRFVNP
     DTGRVLFECK LHKSGYVTVA HTGQHDLVIP PNGYFRFDSW VNQFYTLAPM GNGTGRRRAL
//
